UnitedHealth Group Inc (NYSE:UNH) Shares Bought by Raymond James Trust N.A.

Raymond James Trust N.A. lifted its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 0.8% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 51,799 shares of the healthcare conglomerate’s stock after purchasing an additional 435 shares during the period. UnitedHealth Group accounts for 0.7% of Raymond James Trust N.A.’s holdings, making the stock its 27th biggest position. Raymond James Trust N.A.’s holdings in UnitedHealth Group were worth $12,807,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently made changes to their positions in the company. Vanguard Group Inc grew its stake in UnitedHealth Group by 1.6% during the third quarter. Vanguard Group Inc now owns 69,342,549 shares of the healthcare conglomerate’s stock worth $18,447,892,000 after purchasing an additional 1,073,505 shares during the period. BKD Wealth Advisors LLC lifted its holdings in shares of UnitedHealth Group by 18.0% in the fourth quarter. BKD Wealth Advisors LLC now owns 6,064 shares of the healthcare conglomerate’s stock valued at $1,511,000 after purchasing an additional 926 shares in the last quarter. Lourd Capital LLC lifted its holdings in shares of UnitedHealth Group by 25.9% in the fourth quarter. Lourd Capital LLC now owns 2,911 shares of the healthcare conglomerate’s stock valued at $725,000 after purchasing an additional 598 shares in the last quarter. Hudson Valley Investment Advisors Inc. ADV lifted its holdings in shares of UnitedHealth Group by 23.3% in the fourth quarter. Hudson Valley Investment Advisors Inc. ADV now owns 30,015 shares of the healthcare conglomerate’s stock valued at $7,477,000 after purchasing an additional 5,664 shares in the last quarter. Finally, Oakbrook Investments LLC lifted its holdings in shares of UnitedHealth Group by 8.8% in the fourth quarter. Oakbrook Investments LLC now owns 50,220 shares of the healthcare conglomerate’s stock valued at $12,511,000 after purchasing an additional 4,045 shares in the last quarter. Institutional investors own 85.74% of the company’s stock.

In other UnitedHealth Group news, Director Richard T. Burke sold 10,000 shares of the stock in a transaction on Wednesday, April 24th. The stock was sold at an average price of $229.75, for a total transaction of $2,297,500.00. Following the sale, the director now directly owns 187,663 shares in the company, valued at approximately $43,115,574.25. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Richard T. Burke sold 5,000 shares of UnitedHealth Group stock in a transaction dated Tuesday, March 19th. The stock was sold at an average price of $257.32, for a total value of $1,286,600.00. Following the completion of the transaction, the director now owns 182,454 shares of the company’s stock, valued at approximately $46,949,063.28. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 40,000 shares of company stock valued at $9,679,100. 0.87% of the stock is owned by company insiders.

Shares of UNH traded up $0.41 during mid-day trading on Friday, hitting $245.37. The stock had a trading volume of 2,165,500 shares, compared to its average volume of 4,985,756. The firm has a market cap of $232.36 billion, a PE ratio of 19.05, a PEG ratio of 1.31 and a beta of 0.66. The company has a debt-to-equity ratio of 0.63, a current ratio of 0.73 and a quick ratio of 0.73. UnitedHealth Group Inc has a 52 week low of $208.07 and a 52 week high of $287.94.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $3.73 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $3.60 by $0.13. The firm had revenue of $60.30 billion for the quarter, compared to analyst estimates of $59.72 billion. UnitedHealth Group had a return on equity of 25.07% and a net margin of 5.45%. The business’s revenue was up 9.2% on a year-over-year basis. During the same period in the previous year, the company posted $3.04 earnings per share. Sell-side analysts anticipate that UnitedHealth Group Inc will post 14.71 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 25th. Investors of record on Monday, June 17th will be given a dividend of $1.08 per share. This represents a $4.32 annualized dividend and a yield of 1.76%. This is a boost from UnitedHealth Group’s previous quarterly dividend of $0.90. The ex-dividend date of this dividend is Friday, June 14th. UnitedHealth Group’s payout ratio is presently 27.95%.

UNH has been the topic of a number of recent research reports. ValuEngine lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday, February 27th. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, March 19th. SunTrust Banks dropped their target price on UnitedHealth Group to $300.00 and set a “buy” rating on the stock in a report on Wednesday, April 17th. They noted that the move was a valuation call. Raymond James dropped their target price on UnitedHealth Group from $310.00 to $265.00 and set a “strong-buy” rating on the stock in a report on Wednesday, April 17th. Finally, Morgan Stanley dropped their price target on UnitedHealth Group from $315.00 to $285.00 and set an “overweight” rating on the stock in a report on Wednesday, April 17th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, eighteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. UnitedHealth Group currently has a consensus rating of “Buy” and a consensus price target of $290.84.

TRADEMARK VIOLATION NOTICE: “UnitedHealth Group Inc (NYSE:UNH) Shares Bought by Raymond James Trust N.A.” was originally posted by Rockland Register and is owned by of Rockland Register. If you are viewing this article on another publication, it was illegally stolen and republished in violation of United States and international copyright and trademark legislation. The correct version of this article can be read at https://rocklandregister.com/2019/06/14/unitedhealth-group-inc-unh-shares-bought-by-raymond-james-trust-n-a.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Story: How to Trade Using Analysts Ratings

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.